A former radiologist turned investor, Christoph Ruedig discusses his journey to healthtech from medical school and radiology to management consulting, an MBA from Insead and now being Partner at AlbionVC. One of the original doctor-turned-investors, Christoph has been investing for over a decade since the days that healthtech was called healthcare I.T. !

We discuss Albion, a venture capital fund manager with circa £850M in assets under management and their investing thesis. Christoph highlights a couple of AlbionVC’s healthtech portfolio companies. We also touch on what makes a good board, the benefits of doing an MBA and what healthtech companies should think about in a market downturn.

As another radiologist-turned-investor, I have found Christoph to be an inspiration and support to me. I hope you enjoy this conversation.